Literature DB >> 18059313

Interleukin 2: from immunostimulation to immunoregulation and back again.

Martin F Bachmann1, Annette Oxenius.   

Abstract

Interleukin 2 (IL-2) was one of the first cytokines to be discovered. However, the complex role of IL-2 and its receptor in the regulation of immune responses is only now emerging. This review explores the various signals triggered by IL-2 and discusses their translation into biological function. A model is outlined that accommodates the seemingly contradictory functions of IL-2, and explains how one cytokine can be an essential T-cell growth and differentiation factor and yet also be indispensable to maintain peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059313      PMCID: PMC2267244          DOI: 10.1038/sj.embor.7401099

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  83 in total

1.  Signals from CD28 induce stable epigenetic modification of the IL-2 promoter.

Authors:  Rajan M Thomas; Ling Gao; Andrew D Wells
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Recall proliferation potential of memory CD8+ T cells and antiviral protection.

Authors:  Martin F Bachmann; Petra Wolint; Katrin Schwarz; Annette Oxenius
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

3.  Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells.

Authors:  John K Northrop; Rajan M Thomas; Andrew D Wells; Hao Shen
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 4.  Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis.

Authors:  Averil Ma; Rima Koka; Patrick Burkett
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

5.  Differential regulation of T-cell growth by IL-2 and IL-15.

Authors:  Georgina H Cornish; Linda V Sinclair; Doreen A Cantrell
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

6.  Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.

Authors:  Louise M D'Cruz; Ludger Klein
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

7.  A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

8.  CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Authors:  Edith M Janssen; Nathalie M Droin; Edward E Lemmens; Michael J Pinkoski; Steven J Bensinger; Benjamin D Ehst; Thomas S Griffith; Douglas R Green; Stephen P Schoenberger
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

9.  Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Authors:  Onur Boyman; Marek Kovar; Mark P Rubinstein; Charles D Surh; Jonathan Sprent
Journal:  Science       Date:  2006-02-16       Impact factor: 47.728

10.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

View more
  74 in total

1.  Human Articular Chondrocytes Induce Interleukin-2 Nonresponsiveness to Allogeneic Lymphocytes.

Authors:  Satomi Abe; Hitoshi Nochi; Hiroshi Ito
Journal:  Cartilage       Date:  2016-08-02       Impact factor: 4.634

2.  Co-expression of tumor antigen and interleukin-2 from an adenoviral vector augments the efficiency of therapeutic tumor vaccination.

Authors:  Benjamin Anderschou Holbech Jensen; Maria Abildgaard Steffensen; Karen Nørgaard Nielsen; Jan Pravsgaard Christensen; Allan Randrup Thomsen; Peter Johannes Holst
Journal:  Mol Ther       Date:  2014-07-15       Impact factor: 11.454

Review 3.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

4.  CLARITY-BPA: Effects of chronic bisphenol A exposure on the immune system: Part 2 - Characterization of lymphoproliferative and immune effector responses by splenic leukocytes.

Authors:  Jinpeng Li; Anthony Bach; Robert B Crawford; Ashwini S Phadnis-Moghe; Weimin Chen; Shawna D'Ingillo; Natalia Kovalova; Jose E Suarez-Martinez; Jiajun Zhou; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicology       Date:  2018-02-07       Impact factor: 4.221

5.  Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.

Authors:  Aki Furusawa; John Reiser; Kavitha Sadashivaiah; Haley Simpson; Arnob Banerjee
Journal:  J Immunother       Date:  2018 Feb/Mar       Impact factor: 4.456

Review 6.  Changes of T-cell Immunity Over a Lifetime.

Authors:  Yeqi Nian; Koichiro Minami; Ryoichi Maenesono; Jasper Iske; Jinrui Yang; Haruhito Azuma; Abdala ElKhal; Stefan G Tullius
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

Review 7.  Early programming and late-acting checkpoints governing the development of CD4 T-cell memory.

Authors:  Kunal Dhume; Karl Kai McKinstry
Journal:  Immunology       Date:  2018-05-21       Impact factor: 7.397

Review 8.  Immunotherapy of advanced renal cell carcinoma: Current and future therapies.

Authors:  David Gill; Andrew W Hahn; Guru Sonpavde; Neeraj Agarwal
Journal:  Hum Vaccin Immunother       Date:  2016-08-05       Impact factor: 3.452

9.  Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.

Authors:  Vaishali R Moulton; Alexandros P Grammatikos; Lisa M Fitzgerald; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

Review 10.  Anti-viral CD8 T cells and the cytokines that they love.

Authors:  Maureen A Cox; Shannon M Kahan; Allan J Zajac
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.